4d
Interesting Engineering on MSNStanding against paralysis: Breakthrough stem cell treatment sparks hope worldwideOnce damaged, it has limited ability to heal, leaving millions of people worldwide with permanent paralysis. However, a ...
A paralysed man can stand on his own after receiving an injection of neural stem cells to treat his spinal cord injury. The ...
1d
India Today on MSNParalysed man can stand again with breakthrough stem cell therapy in JapanThe paralysed man can stand again after receiving experimental stem cell therapy. He was given an injection of neural stem ...
Cord blood transplants—considered an adult stem cell therapy because the cells come from infants, not embryos—have been performed since 1988. Like bone marrow, which doctors have been ...
Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate ... activities in the OA joint. Targeted gene therapy might further enhance these activities of MSCs.
The next frontier of stem cell transplantation might involve the eyes. In research out today, scientists report that an experimental therapy has helped people with otherwise untreatable injuries ...
Autism rates have tripled over the last 16 years. Although the causes and resulting manifestations of Autism Spectrum ...
Trials undertaken so far have shed light on several complications that cast doubt on the safety of regenerative therapy in humans. Initial concerns about tumorigenicity after adult stem cell ...
He not only highlighted the success stories of using adult stem cell therapy and platelet-rich plasma therapy in treating patients with conditions such as stroke, arthritis, cerebral palsy ...
In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over five years to co-fund a major study of mesenchymal (adult) stromal cells as a new ...
Nuvo Medical Associates recently opened at 5480 Valmont Road and specializes in stem cell therapy and platelet-rich plasma ...
From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 million upfront, building out another cancer-targeting approach.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results